2019 MASCC/ISOO Annual Meeting on Supportive Care in Cancer

 

2019 MASCC/ISOO Annual Meeting on Supportive Care in Cancer
R

Fixed-Dose 7.5 mg Rasburicase Is Safe and Cost-Effective in Preventing Tumour Lysis Syndrome in Adult Haematology Patients at University College London Hospitals (UCLH) NHS Trust

By 2019 MASCC/ISOO Annual Meeting on Supportive Care in Cancer FEATURING Raakhee Shah, Rebecca Burgoyne
By 2019 MASCC/ISOO Annual Meeting on Supportive Care in Cancer FEATURING Raakhee Shah, Rebecca Burgoyne
13 views
September 11, 2019
0 Comments
Login to view comments. Click here to Login

Featured Video

15:07
Exelixis

Safety and Efficacy Data of a TKI Monotherapy in HCC

Feat. J. Mizrahi

Featured Video

06:51
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Prevalence and Prediction of Ruxolitinib Tr…

Feat. D. Tremblay
Young Investigator Parallel Session
09:36
2019 MASCC/ISOO Annual Meeting on Supportive Care in Cancer

Reflections of an Experienced Investigator

Feat. J. Epstein
14:40
2019 MASCC/ISOO Annual Meeting on Supportive Care in Cancer

Prophylactic Gabapentin in HNC

Feat. D. Smith
07:59
2019 MASCC/ISOO Annual Meeting on Supportive Care in Cancer

Fixed-Dose 7.5 mg Rasburicase Is Safe and Cost-Effective in Preventi…

Feat. R. Shah, R. Burgoyne
09:35
2019 MASCC/ISOO Annual Meeting on Supportive Care in Cancer

Symptoms Predictive of Overall Quality of Life Using the Edmonton Sy…

Feat. S. Chow
11:35
2019 MASCC/ISOO Annual Meeting on Supportive Care in Cancer

Association of Frailty With Emotional Health of Older Patients With …

Feat. N. Gilmore
13:31
2019 MASCC/ISOO Annual Meeting on Supportive Care in Cancer

Treatment-Related Mortality in Children with Acute Lymphoblastic Leu…

Feat. R. Ul-Ain